Withings has introduced the Body Scan 2, a $599.95 smart scale with a focus on cardiovascular and metabolic health, featuring eight electrodes on the scale and four in a retractable handle for more accurate body composition readings. The scale tracks over 60 biomarkers, including a 90-second "longevity assessment" that evaluates heart, artery, cellular, and metabolic health, providing users with a simplified Health Trajectory score. Unlike other health tech devices that rely on invasive blood tests, the Body Scan 2 uses bioimpedance spectroscopy and foot sweat analysis to noninvasively monitor metabolic health. While the scale aims to be a comprehensive "longevity station," challenges such as emotional impacts and regulatory approvals remain, with Withings planning to release the scale in Q2 2026. This matters because it represents a shift in how everyday health monitoring devices can provide early health warnings and insights beyond traditional weight measurement.
